# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000885590-23-000009
Filing Date
2023-02-23
Accepted
2023-02-23 16:37:29
Documents
156
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | bhc-20221231.htm iXBRL | 10-K | 5817523
2 | EX-21.1 | exhibit2112022ye.htm | EX-21.1 | 146644
3 | EX-23.1 | exhibit2312022ye.htm | EX-23.1 | 2396
4 | EX-31.1 | exhibit3112022ye.htm | EX-31.1 | 9900
5 | EX-31.2 | exhibit3122022ye.htm | EX-31.2 | 9858
6 | EX-32.1 | exhibit3212022ye.htm | EX-32.1 | 6432
7 | EX-32.2 | exhibit3222022ye.htm | EX-32.2 | 6532
13 | GRAPHIC | bhc-20221231_g1.jpg | GRAPHIC | 58697
| Complete submission text file | 0000885590-23-000009.txt |  | 26104982

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bhc-20221231.xsd | EX-101.SCH | 155081
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bhc-20221231_cal.xml | EX-101.CAL | 141180
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bhc-20221231_def.xml | EX-101.DEF | 939109
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bhc-20221231_lab.xml | EX-101.LAB | 1606473
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bhc-20221231_pre.xml | EX-101.PRE | 1246856
150 | EXTRACTED XBRL INSTANCE DOCUMENT | bhc-20221231_htm.xml | XML | 5341113

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14956 | Film No.: 23660316
SIC: 2834 Pharmaceutical Preparations